142 related articles for article (PubMed ID: 37882915)
1. The upregulation of immune checkpoints after photodynamic therapy reducing immune effect for treating breast cancer.
Long S; Wang B; Cui Y; Shao J; Zhao Y; Xu Y; Li H; Qiu H; Zhao H; Zeng J; Chen D; Li X; Gu Y
Lasers Med Sci; 2023 Oct; 38(1):243. PubMed ID: 37882915
[TBL] [Abstract][Full Text] [Related]
2. Amplifying T cell-mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti-PD1.
Gong B; Wang L; Zhang H; Wang Q; Li W
Cell Biochem Funct; 2024 Jan; 42(1):e3925. PubMed ID: 38269509
[TBL] [Abstract][Full Text] [Related]
3. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers.
Kaneko K; Acharya CR; Nagata H; Yang X; Hartman ZC; Hobeika A; Hughes PF; Haystead TAJ; Morse MA; Lyerly HK; Osada T
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171008
[TBL] [Abstract][Full Text] [Related]
4. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Mollavelioglu B; Cetin Aktas E; Cabioglu N; Abbasov A; Onder S; Emiroglu S; Tükenmez M; Muslumanoglu M; Igci A; Deniz G; Ozmen V
World J Surg Oncol; 2022 Oct; 20(1):349. PubMed ID: 36271406
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8
Kleinovink JW; Fransen MF; Löwik CW; Ossendorp F
Cancer Immunol Res; 2017 Oct; 5(10):832-838. PubMed ID: 28851692
[TBL] [Abstract][Full Text] [Related]
6. Two Molecular Weights Holothurian Glycosaminoglycan and Hematoporphyrin Derivative-Photodynamic Therapy Inhibit Proliferation and Promote Apoptosis of Human Lung Adenocarcinoma Cells.
Hao-Yu D; Ding-Yi Y; Bao-Hong X; Aihua S; Xiao-Qian D; Cun-Zhi L
Integr Cancer Ther; 2023; 22():15347354221144310. PubMed ID: 36624619
[TBL] [Abstract][Full Text] [Related]
7. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
Wang Y; Lin Y; Zhang HG; Zhu J
J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol enhances the effect of photodynamic therapy in human breast cancer.
Peng Z; Liu R; Li Y; Zhang Q; Cai X; Li L
J BUON; 2016; 21(5):1068-1075. PubMed ID: 27837606
[TBL] [Abstract][Full Text] [Related]
9. Active oxygen intermediates in the degradation of hematoporphyrin derivative in tumor cells subjected to photodynamic therapy.
Chekulayeva LV; Chekulayev VA; Shevchuk IN
J Photochem Photobiol B; 2008 Nov; 93(2):94-107. PubMed ID: 18760622
[TBL] [Abstract][Full Text] [Related]
10. TIGIT acts as an immune checkpoint upon inhibition of PD1 signaling in autoimmune diabetes.
Trivedi P; Jhala G; De George DJ; Chiu C; Selck C; Ge T; Catterall T; Elkerbout L; Boon L; Joller N; Kay TW; Thomas HE; Krishnamurthy B
Front Immunol; 2024; 15():1370907. PubMed ID: 38533515
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide, superoxide, and hydroxyl radicals are involved in the phototoxic action of hematoporphyrin derivative against tumor cells.
Chekulayeva LV; Shevchuk IN; Chekulayev VA; Ilmarinen K
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):51-77. PubMed ID: 16566710
[TBL] [Abstract][Full Text] [Related]
12. Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1
Liang H; Li H; Xie Z; Jin T; Chen Y; Lv Z; Tan X; Li J; Han G; He W; Qiu N; Jiang M; Zhou J; Xia H; Zhan Y; Cui L; Guo W; Huang J; Zhang X; Wu YL
Thorac Cancer; 2020 Oct; 11(10):2941-2954. PubMed ID: 32894006
[TBL] [Abstract][Full Text] [Related]
13. Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors.
Natoli M; Hatje K; Gulati P; Junker F; Herzig P; Jiang Z; Davydov II; Germann M; Trüb M; Marbach D; Zwick A; Weber P; Seeber S; Wiese M; Lardinois D; Heinzelmann-Schwarz V; Rosenberg R; Tietze L; Mertz KD; Umaña P; Klein C; Codarri-Deak L; Kao H; Zippelius A
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36319064
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
Korbelik M; Dougherty GJ
Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands.
Garman B; Jiang C; Daouti S; Kumar S; Mehta P; Jacques MK; Menard L; Manjarrez-Orduno N; Dolfi S; Mukherjee P; Rai SC; Lako A; Koenitzer JD; David JM
Front Immunol; 2023; 14():1151748. PubMed ID: 37795090
[TBL] [Abstract][Full Text] [Related]
16. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoints are predominantly co-expressed by clonally expanded CD4
Bredel D; Tihic E; Mouraud S; Danlos FX; Susini S; Aglave M; Alfaro A; Mohamed-Djalim C; Rouanne M; Halse H; Bigorgne A; Tselikas L; Dalle S; Hartl DM; Baudin E; Guettier C; Vibert E; Rosmorduc O; Robert C; Ferlicot S; Parier B; Albiges L; de Montpreville VT; Besse B; Mercier O; Even C; Breuskin I; Classe M; Radulescu C; Lebret T; Pautier P; Gouy S; Scoazec JY; Zitvogel L; Marabelle A; Bonvalet M
J Exp Clin Cancer Res; 2023 Dec; 42(1):333. PubMed ID: 38057799
[TBL] [Abstract][Full Text] [Related]
18. PD-1
Kamada T; Togashi Y; Tay C; Ha D; Sasaki A; Nakamura Y; Sato E; Fukuoka S; Tada Y; Tanaka A; Morikawa H; Kawazoe A; Kinoshita T; Shitara K; Sakaguchi S; Nishikawa H
Proc Natl Acad Sci U S A; 2019 May; 116(20):9999-10008. PubMed ID: 31028147
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
[TBL] [Abstract][Full Text] [Related]
20. DNA or cell kinetics flow cytometry analysis of 33 small gastrointestinal cancers treated by photodynamic therapy.
Foultier MT; Vonarx-Coinsman V; de Brito LX; Morlet L; Robillard N; Patrice T
Cancer; 1994 Mar; 73(6):1595-607. PubMed ID: 8156486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]